Guillain-Barre syndrome after the first dose of Anti-SARS-CoV-2 vaccination is a rare side effect and the second jab is controversial in these cases.

Indian J Public Health

Additonal Professor and Head, Department of Physical Medicine and Rehabilitation, AIIMS, Patna, Bihar, India.

Published: April 2023

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijph.ijph_1360_22DOI Listing

Publication Analysis

Top Keywords

guillain-barre syndrome
4
syndrome dose
4
dose anti-sars-cov-2
4
anti-sars-cov-2 vaccination
4
vaccination rare
4
rare side
4
side second
4
second jab
4
jab controversial
4
controversial cases
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!